Arno Therapeutics (OTCMKTS:ARNI) Shares Pass Above 50 Day Moving Average – Should You Sell?

Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s share price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares.

Arno Therapeutics Trading Down 100.0 %

Arno Therapeutics Company Profile

(Get Free Report)

Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.

Featured Stories

• Five stocks we like better than Arno Therapeutics
• Should You Invest in Penny Stocks?
• 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
• How to Use High Beta Stocks to Maximize Your Investing Profits
• These 3 Stocks Have Huge Last 12 Months Shareholder Yields
• What Are the U.K. Market Holidays? How to Invest and Trade
• Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?